A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

TY - JOUR

T1 - A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

AU - GOIM (Gruppo Oncologico dell’Italia Meridionale)

AU - Ciccarese, Mariangela

AU - Orlando, Laura

AU - Fedele, Palma

AU - Schiavone, Paola

AU - Maiello, Evaristo

AU - Cilenti, Giuseppina

AU - Aieta, Michele

AU - Bozza, Giovanni

AU - Forcignanò, Rosachiara

AU - Febbraro, Antonio

AU - Bordonaro, Roberto

AU - Romito, Sante

AU - Rinaldi, Antonio

AU - Borsellino, Nicolo'

AU - Riccardi, Ferdinando

AU - Pisconti, Salvatore

AU - Lorusso, Vito

AU - Colucci, Giuseppe

AU - Surico, Giammarco

AU - Saracino, Valeria

AU - Cinieri, Saverio

N1 - Funding Information: We thank Michele di Candia MD for help in the preparation of the manuscript. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85084981817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084981817&partnerID=8YFLogxK

U2 - 10.1111/tbj.13856

DO - 10.1111/tbj.13856

M3 - Comment/debate

C2 - 32436244

AN - SCOPUS:85084981817

VL - 26

SP - 1857

EP - 1859

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 9

ER -